Not yet recruiting NCT07265817
Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Fecal Microbial transplant Capsules, Placebo.
- Who it may be relevant to
- Registry conditions: Carbapenem-Resistant Enterobacteriaceae Colonization. Basic parameters: from 19 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms: Randomized Double Blinded Study
Overview
The aim of the study is to see whether fecal microbiota transplantation is effective to decolonize multidrug-resistant organisms.
Interventions
- Combination product Fecal Microbial transplant Capsules
3 pills per day for 3 consecutive days with placebo comparatator - Combination product Placebo
The same amount and shape capsules
Primary outcome measures
- Conversion to negative organism [Time frame: 1 year]
Eligibility criteria
Inclusion criteria
- Patients who have positive results in PCR or culture of rectal swab.
Exclusion criteria
- Not provide a consent.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Quadruple blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07265817 · KNUH 2023-07-013